Could Your Apple Watch Check Your Blood Glucose Levels? The Technology is Closer Than You May Think

Keerthi Vedantam

Keerthi Vedantam is a bioscience reporter at dot.LA. She cut her teeth covering everything from cloud computing to 5G in San Francisco and Seattle. Before she covered tech, Keerthi reported on tribal lands and congressional policy in Washington, D.C. Connect with her on Twitter, Clubhouse (@keerthivedantam) or Signal at 408-470-0776.

Could Your Apple Watch Check Your Blood Glucose Levels? The Technology is Closer Than You May Think

Wearable technology has come a long way.

The Apple Watch — often touted as a way to help people monitor their steps and sleep — may soon be able to check your blood sugar levels, making it more akin to a medical device.


Rockley Photonics, a photonic sensor company based in Pasadena, has been quietly working on small blood sensors that can be affixed to wearables and parse alcohol intake, blood sugar and glucose levels. Its biggest customer according to a story from the Telegraph is none other than Apple.

The technology reportedly uses sensors on the back of a smartwatch to shine light through the skin in order to assess blood. Apple and another unnamed company account for as much as 100% of Rockley Photonics' revenue, according to SEC filings.

Neither company replied to requests for comment.

Glucose monitors, once used primarily by diabetics, are reaching the masses. Increasingly companies are offering glucose monitoring services as the obsession with micromanaging one's health grows.

January.ai is a California-based metabolism tracker startup that provides continuous glucose monitors (CGMs) to subscribers, and uses AI to predict what kind of exercise users need to maintain their health. The sticker price for a package is $488. Another —Levels — pairs with an existing CGM to track one's glucose levels at $395. With the added cost of sensors that need to be ordered frequently, these services are out of reach for many, especially for those with type 2 diabetes which has a high correlation with poverty.

What makes glucose monitors more attractive than traditional blood tests is that they continuously track, allowing users to see which foods spike their blood sugar, since different foods have varying results on individuals.

It is unclear if Apple will use this blood sugar monitor the same way January.ai has, but the company (and Rockley) are toeing the line between a consumer health wearable and an actual medical device, which would need to get approval from the Food and Drug Administration. It's a process that could take years to complete, which is incompatible with Apple's typical innovation cycles.

The advent of 24/7 blood sugar monitors that have smartphone capabilities for people to store, track and send data, have been a game changer for diabetics and physicians — doctors can more accurately treat patient health.

"There's also patients who are eating right and are taking all their medicines as prescribed and sometimes putting a CGM on them shows us that, 'oh wow, we've been just treating this patient incorrectly'," said Khan.

But dedicated glucose monitors aren't always reliable — Dexcom came under fire in 2019 when its system stopped notifying patients when their blood sugar was too high or too low, and a parent monitoring their children's diabetes said he was afraid to drop her off at school in case the system failed again.

"These wearable technologies are only as useful to the patients as they are accurate and precise," Khan said. "But because they're so fine-tuned to our diabetes patients, they're a lot less prone to error."

"I certainly wouldn't tell my patients to dose their insulin based on what their Apple Watch is telling them," Khan said. "I would tell them to trust their sensor or trust their fingerstick."

https://twitter.com/KeerthiVedantam
keerthi@dot.la

Subscribe to our newsletter to catch every headline.

LA Tech ‘Moves’: Mapp Gains New CPO and CTO, Prodoscore Taps Boeing Exec

Decerry Donato

Decerry Donato is a reporter at dot.LA. Prior to that, she was an editorial fellow at the company. Decerry received her bachelor's degree in literary journalism from the University of California, Irvine. She continues to write stories to inform the community about issues or events that take place in the L.A. area. On the weekends, she can be found hiking in the Angeles National forest or sifting through racks at your local thrift store.

LA Tech ‘Moves’: Mapp Gains New CPO and CTO, Prodoscore Taps Boeing Exec
LA Tech ‘Moves’:

“Moves,” our roundup of job changes in L.A. tech, is presented by Interchange.LA, dot.LA's recruiting and career platform connecting Southern California's most exciting companies with top tech talent. Create a free Interchange.LA profile here—and if you're looking for ways to supercharge your recruiting efforts, find out more about Interchange.LA's white-glove recruiting service by emailing Sharmineh O’Farrill Lewis (sharmineh@dot.la). Please send job changes and personnel moves to moves@dot.la.

***

Read moreShow less

This Week in ‘Raises’: GITAI Lands $30M, Steno Gains $15M

Decerry Donato

Decerry Donato is a reporter at dot.LA. Prior to that, she was an editorial fellow at the company. Decerry received her bachelor's degree in literary journalism from the University of California, Irvine. She continues to write stories to inform the community about issues or events that take place in the L.A. area. On the weekends, she can be found hiking in the Angeles National forest or sifting through racks at your local thrift store.

Raises
Image by Joshua Letona

A local space robotics startup raised fresh funding to expand the flight model manufacturing facilities throughout the U.S. and increase employment, while a remote litigation platform raised more funding to continue growing its footprint in new markets across the country, develop service channels for its clients and continue expanding its tech team.

***

Read moreShow less

Gitai Raises $30 Million to Expand Manufacturing Footprint in Los Angeles

Samson Amore

Samson Amore is a reporter for dot.LA. He holds a degree in journalism from Emerson College. Send tips or pitches to samsonamore@dot.la and find him on Twitter @Samsonamore.

Gitai Raises $30 Million to Expand Manufacturing Footprint in Los Angeles
\u200bPhoto: Gitai

Space robotics company Gitai raised a $30 million Series B extension this week, bringing the total value of the round to roughly $47 million.

The funding will be used to further develop Gitai’s suite of space robots as well as build out its manufacturing footprint in Torrance. Previously Gitai announced it raised a $17.1 million Series B in March 2021; this additional raise is still part of that round.

Read moreShow less
https://twitter.com/samsonamore
samsonamore@dot.la
RELATEDEDITOR'S PICKS
LA TECH JOBS
interchangeLA
Trending